South Wales, Feb. 20 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Renodyra" on Feb. 5. The details about the trademark application no. UK00004336207 published in the journal no. 2026/008 (Feb. 20).
With Swindell & Pearson Limited as representative, Penlan Healthcare Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals; pharmaceutical products for the treatment of disease of the genitourinary system; pharmaceutical products for the treatment of crystallopathy; pharmaceutical products for the treatment of urinary stone disease; pharmaceutical products for the treatment of kidney stone disease; pharmaceutical products for the treatment of renal calculus disease; pharmaceutical products for the treatment of renal calculus; pharmaceutical products for the treatment of kidney stones; pharmaceutical products for the treatment of recurrent renal calculus; pharmaceutical products for the treatment of recurrent kidney stones; pharmaceutical products for the treatment of hypocitraturia; pharmaceutical products for the treatment of chronic calcium oxalate stone; pharmaceutical products for the treatment of recurrent uric acid lithiasis; pharmaceutical products for the treatment of renal tubular acidosis; pharmaceutical products for the treatment of renal tubular acidosis with calcium nephrolithiasis; pharmaceutical products for the treatment of renal tubular acidosis; pharmaceutical products for the treatment of recurrent uric acid lithiasis without calcium lithiasis and cysteine lithiasis; pharmaceutical products for the treatment of recurrent uric acid lithiasis with calcium lithiasis and cysteine lithiasis.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004336207
Disclaimer: Curated by HT Syndication.
